CEACAM5 and neoplasm: Although novel biomarkers such as circulating tumor DNA (ctDNA) are currently under investigation1, serum carcinoembryonic antigen (CEA) is still the most widely used tumor marker for colorectal cancer (CRC) worldwide2,3.